Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 2547169 | https://doi.org/10.1155/2016/2547169

Madona Khoury, Didier Stien, Véronique Eparvier, Naïm Ouaini, Marc El Beyrouthy, "Report on the Medicinal Use of Eleven Lamiaceae Species in Lebanon and Rationalization of Their Antimicrobial Potential by Examination of the Chemical Composition and Antimicrobial Activity of Their Essential Oils", Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 2547169, 17 pages, 2016. https://doi.org/10.1155/2016/2547169

Report on the Medicinal Use of Eleven Lamiaceae Species in Lebanon and Rationalization of Their Antimicrobial Potential by Examination of the Chemical Composition and Antimicrobial Activity of Their Essential Oils

Academic Editor: Nativ Dudai
Received04 Jul 2016
Revised29 Sep 2016
Accepted04 Oct 2016
Published08 Dec 2016

Abstract

Many Lamiaceae species are consumed in the Lebanese cuisine as food or condiment and are largely used in the traditional medicine of Lebanon to treat various diseases, including microbial infections. In this article we report the traditional medicinal uses of eleven Lamiaceae species: Coridothymus capitatus L., Lavandula stoechas L., Lavandula angustifolia Mill., Mentha spicata L. subsp. condensata, Origanum syriacum L., Rosmarinus officinalis, Salvia fruticosa Miller., Satureja cuneifolia Ten., Satureja thymbra L., Thymbra spicata L., and Vitex agnus-castus L. and study the chemical composition and antimicrobial activity of their essential oils (EOs). Our survey showed that Lamiaceae species are mainly used against gastrointestinal disorders and microbial infections. Chemical analysis of the EOs obtained from these plants allowed us to identify seventy-five compounds describing more than 90% of the relative composition of each EO. Essential oils with high amounts of thymol and carvacrol possessed the strongest antimicrobial activity. As expected, these two compounds demonstrated an interesting antifungal efficacy against the filamentous fungus T. rubrum. Our results confirmed that some of the Lamiaceae species used in Lebanon ethnopharmacological practices as antimicrobial agents do possess antibacterial and antifungal potential consistent with their use in alternative or complementary medicine.

1. Introduction

The evolution of resistance to currently used antimicrobial compounds is neither a surprising nor a new phenomenon; however, infections are becoming more common, more severe, and more easily transmitted. According to the WHO, many infectious diseases will become untreatable and uncontrollable in the upcoming years [1]. Many authors mention a possible upcoming postantibiotic era [24].

Aromatic plants have been recognized since antiquity and widely used as bactericides, fungicides, virucides, antiparasitics, and pesticides. Their properties are mainly attributed to their volatile oils [5, 6]. Investigations into the antimicrobial activities, mode of action, and potential uses of plant essential oils have regained momentum [7]. These oils, representative of very wide chemical diversity, may contribute to or inspire alternative solutions against multidrug resistant infections. Recently, in vitro screening programs based on ethnobotanical approaches proved to be very efficient in validating traditional uses of medical plants and providing new ways in the search for active compounds [8].

Lamiaceae (formerly known as Labiatae) is a large plant family of mostly shrubs and herbs. It is the largest family of the order Lamiales with 236 genera and more than 7,000 species, the largest genus being Salvia with around 900 species [9]. Lamiaceae are distributed globally and a particularly high concentration of them occurs in the Mediterranean region. The majority of Lamiaceae being aromatic plants, the family is economically important [10]. Many are cultivated as ornamentals, like Ajuga, Coleus, and Salvia but others are widely used as culinary herbs and spices, such as sage (Salvia), thyme (Thymus), mint (Mentha), oregano or marjoram (Origanum), rosemary (Rosmarinus), lavender (Lavandula), and basil (Ocimum). Mint and lavender are grown for their oil used in perfumery, cosmetics, pharmaceutical, and food industries as active ingredients or as flavour and fragrance. Medicinal properties of the Lamiaceae species are often attributed to their high content of volatile compounds.

The Lamiaceae family is particularly well represented in Lebanon, where 136 species belonging to 29 genera have been inventoried [11]. Many Lamiaceae are regularly consumed in the Lebanese cuisine as food or condiments. For example, the different varieties of thyme like Origanum syriacum, Satureja thymbra, and Thymbra spicata associated with a mixture of Rhus coriaria L. (sumac) and sesame seeds are the main ingredients of a very popular Lebanese pizza called “manakeesh.” Others, like Rosmarinus officinalis, Coridothymus capitatus, and Salvia fruticosa, are eaten as salads and the leaves of Thymus and Origanum species are mixed with traditional Lebanese fresh cheese called “Shanklish” for their aromatic and antiparasitic properties.

Indigenous Lamiaceae are also frequently used in Lebanon for medical purposes and are marketed by herbalists. These include the genera Lavandula, Melissa, Mentha, Origanum, Rosmarinus, Salvia, Satureja, and Thymus. These plants are highly aromatic due to the presence of external glandular structures that produce volatile oil [12] and their essential oils are widely used in the Lebanese folk medicine [11, 13, 14].

However, there was no previous study documenting the folk medicinal usage of the Lamiaceae species in Lebanon. We have conducted a large-scale survey on the traditional medicinal uses of Lamiaceae species in different regions of Lebanon. A part of this work has already appeared in a congress report [11].

The main objectives of the present study were (1) to report on the traditional uses of eleven Lamiaceae species most used in the Lebanese folk medicine (Coridothymus capitatus L. Reichenb. Fil., Lavandula stoechas L., Lavandula angustifolia Mill., Mentha spicata L. subsp. condensata, Origanum syriacum L., Rosmarinus officinalis L., Salvia fruticosa Miller., Satureja cuneifolia Ten., Satureja thymbra L., Thymbra spicata L., and Vitex agnus-castus L.), (2) to investigate the chemical composition of the EOs extracted from these species, (3) to evaluate the antimicrobial activity of these EOs and their major constituents against opportunistic human pathogens, and (4) to correlate in vitro results with the ethnopharmacological uses of these plants.

2. Material and Methods

2.1. Ethnomedical Field Survey and Ethnobotanical Data Collection

The research was carried out in different regions of Lebanon from the north to the south and from the coast to the mountains, including the anti-Lebanon mountain range and the steppe. A great variety of wild plant species according to different ecological conditions can therefore be found. The surveys were conducted in the cities and villages of the twenty-five districts (“aqdya” or “qadaa”) of the six governorates (“mohaafazah”) of Lebanon (Figure 1).

Ethnobotanical and ethnomedicinal information was obtained between the years 2002 and 2008 from 325 interviewees from 223 villages covering all the districts of Lebanon. Most of the participants interviewed were herbalists (“Attarin” or “dabbous”), shepherds, farmers, folk healers, or older experienced people and midwives (“daye”) between 40 and 70 years old. The people interviewed declared that their knowledge about the traditional medicine was transmitted mainly orally from older generations. Interviewees were accompanied to the field individually where they would point out the herbs that have been using to cure the mentioned disease. This was also to confirm plant identification (vernacular names can be different in different regions of Lebanon) and obtain fresh samples for herbarium voucher. When the fertile part was not available, the plant was visited again at the appropriate time to obtain a fertile sample.

The obtained information was cross-checked with that of other informants, and also, after a week, the interview was repeated with the same person. Only medical usages of plants given at least by three separate informants have been reported in this investigation. It was verified that each informant is able to recognize the mentioned plant species in the wild.

The questionnaire form was based on the botanical and ethnopharmacognosic survey of traditional medicine plants, suggested by WHO [15]. The collected information included local names, used part(s) of the plant, folk medicinal uses and therapeutic properties, method of preparation, way of administration, doses, and duration of treatment. The results are recorded in a synoptic table (Table 2).

2.2. Plant Material

Plant material was collected in several locations throughout Lebanon and voucher specimens were deposited at the Herbarium of Botany of the U.S.E.K., Lebanon. Specimens of the Lamiaceae species were collected as described in Table 1.


Plant namePart usedCollection regionCollection dateVoucher number
RegionDistrictGPS LocationAltitude (m)

Coridothymus capitatusFlowering topsAnfehKoura34°21′38.69′′N
35°43′58.96′′E
8August 2011MNV191a
Lavandula angustifoliaFlowering topsQartabaMount Lebanon34°05′39.18′′N
35°50′38.99′′E
1170May 2012MNC121
Lavandula stoechasFlowering topsAdonisKeserwan33°58′05.91′′N
35°36′35.20′′E
50May 2012MNV114
Mentha spicataFlowering topsKfarzebianMount Lebanon33°59′53.43′′N
35°51′29.69′′E
2015July 2012MNV194
Satureja cuneifoliaLeavesMNV173
Origanum syriacumFlowering topsAlitaKeserwan34°05′29.72′′N
35° 41′27.05′′E
620August 2012MNV188
Rosmarinus officinalisLeavesShuwayfatMount Lebanon34°48′32.43′′N
33°48′32.43′′E
200October 2011MNV154
Salvia fruticosaLeavesNahr IbrahimMount Lebanon34°04′24.34′′N
35°39′19.03′′E
190June 2012MNV159
Satureja thymbraFlowering topsMNV173a
Thymbra spicataLeavesMNV191
Vitex agnus-castusFlowering topsNahr IbrahimMount Lebanon34°03′42.70′′N
35°38′44.52′′E
7June 2012MNV096


Scientific nameCommon nameVernacular names in LebanonPart usedPreparationTraditional medicinal indication in LebanonFr (%)

Coridothymus capitatus (L.) Reichenb. FilConehead ThymeZa’atar farisi
Za’atar ‘assal
Za’atar
FpI: infusion or decoction on an empty stomach, one cup in the morningGastrointestinal disorders (colics, gastritis, stomach aches, carminative) (5, 6, 9, 15)164.9
Antidiarrheal (6, 15)61.8
Antiemetic (5, 9)51.5
Antihypertensive (6, 9)61.8
Vermifuge (5, 6, 15)41.2
Spasmolytic (15)51.5
Acne (9)41.2
Antiseptic (6, 9, 15)92.8
I: cold infusionDermatosis (5, 15)41.2
LeI: infusion, 1 teaspoon in a cup of water, drinking 3 cups per dayCough, pneumonia, expectorant (5, 6, 15)82.5
Hypoglycemic (6, 15)51.5
Stomachic (5, 6)61.8
Febrifuge (6)30.9

Lavandula stoechas L.Spanish lavenderAstakhoudos Khuzama
Shih
FpI: infusion, 1 or 2 cups per dayAntiseptic (2, 9, 12, 20, 22)103.1
Gastrointestinal disorders (9, 12, 20)72.1
Spasmolytic (12, 17, 22)51.5
Rheumatism (2, 20)61.8
Cardiotonic (9, 17, 22)61.8

Lavandula angustifolia Mill. ()Common lavender or English lavenderKhuzama
Lawanda
Fp
Le
St
I: infusion, 2 cups per dayHypoglycemic (6, 12, 14, 18, 20)103.1
Antihypertensive (12, 18, 20)92.8
Hepatitis (14, 20)72.1
Antiseptic (6, 14, 18)92.8
Dermatitis (6, 18, 20)82.5
Migraine (12, 18)30.9
Flu (14, 18)41.2
Asthenia, stimulant (14, 20)51.5
Stomachic, antispasmodic, carminative (6, 12, 14, 18)113.4
Sedative (6, 12, 20)41.2
Uricemia (12)30.9
Diuretic (12, 18)61.8
E: EO massageHealing (14, 17)82.5
Rheumatism (14, 17)92.8
Lumbago (17)41.2

Mentha spicata L. subsp. condensata (Briq.) Greuter & BurdetWild mintNa’ana’a barriLeI: infusionDigestive disorders (12, 17, 20, 24, 25)123.7
Antimicrobial (12, 20, 25)92.8
Gastritis (17, 24, 25)51.5
Antiemetic (17, 24)41.2
Arthritis (12, 20)41.2

Origanum syriacum L.Biblical-hyssop, Lebanese oregano, or Syrian oreganoZouba’ Za’atarFpI: decoction mixed with honey 2 cups per day; food mixturesAntiseptic, antimicrobial (1, 8, 10, 11, 12, 13, 14, 26)154.6
Vermifuge (8, 11, 14)82.5
Pertussis (10, 12, 13)61.8
Antihypertensive (1, 10, 14, 26)103.1
Hypoglycemic (11, 12, 13)72.1
Stomachic (1, 13, 14, 26)92.8
Spasmolytic (8, 11, 12)72.1
Antidiarrheal (11, 13, 14)82.5
Rheumatism (1, 12, 26)82.5
Asthma (1, 8)72.1
Migraine (13, 14)61.8
Appetizer (8, 26)51.5
Stimulating memory (13)61.8
LeI: infusion 20 g/L; 250–500 mL/dayCough, expectorant (2, 9)61.8
Vermifuge (2)51.5
Constipation (9)30.9
I: infusion, drinking dailyBronchitis (18, 22)41.2
Hypoglycemia (22)30.9
I: infusion, 1 teaspoon in a cup of waterAntihypertensive (12, 14)61.8
Gastrointestinal disorders (8, 12, 14)82.5
E: local application mixed with olive oilAnalgesic (2, 14)61.8
Rheumatism (2, 12)61.8
Antihypertensive (14)51.5
I: saladsAntiseptic (1, 2, 8)61.8
Antidote, blood purifying (1, 8)41.2
FlE: maceration and local applicationRheumatism (1, 8, 12, 14, 16, 22)3310.1
E: EO mixed with olive oil and local application185.5

Rosmarinus officinalis L. RosemaryEklil-al-jabal
Hasa-al-bān
Nada-al-bahr
Fp
Le
St
I: decoction with distilled water once a dayAntiseptic (2, 12, 14, 25)164.9
Antifungal (12, 20, 25)113.4
Hypoglycemic (2, 14, 20)134.0
Stomachic (2, 12, 25)123.7
Carminative (20, 25)82.5
Antianemic (14)72.1
Febrifuge (14, 20)41.2
Constipation (2, 25)61.8
Splenomegaly (20)51.5
Emmenagogue (12, 20)41.2
Cholagogue (2, 14)51.5
LeI: infusion 30 g/L of water, drinking one cup, 3 times a day until improvementLiver diseases (13, 18)51.5
Arteriosclerosis, cardiotonic (7, 13)61.8
Antianemic (13)30.9
Asthma (7)30.9
E: macerated in alcohol and locally applied or leaves added to bathRheumatism (1, 22, 23)288.6
E: EO diluted in alcohol and water and local applicationAntiseptic (4,19, 21)268.0
E: EO mixed with olive oil and applied locally to the affected areas; alcohol macerate decoctionRheumatism (2, 12, 14)319.5

Salvia fruticosa Miller.SageAiza’an
Kassiin
‘Ouaissé
Maryamiyyé
Fp
Le
I: decoctionStimulating memory (2, 3, 5, 12, 14)82.5
Hypoglycemic (2, 5)185.5
Rheumatism (3, 5, 12)206.1
Influenza (3, 14)144.3
Antihypertensive (5, 12, 14)164.9
Gastralgia (2, 12)123.7
Hepatitis (3, 5)92.8
Nephropathy (5, 12)82.5
Constipation (2, 14)113.4
Carminative (3, 14)134.0
I: 3 drops of EO added to one tablespoon of honeyHypoglycemic (12, 14)92.8
Cough, expectorant (2, 14, 15)134.0
Spasmolytic (12)51.5
Antimicrobial, antiseptic (1, 13, 15)103.1
Febrifuge (13)41.2
Rheumatism (1, 13, 15)82.5
LeI: decoctionArthritis (13, 14, 15)226.8
I: infusionStomachic (2, 9, 12, 15)92.8
Aphrodisiac (12)51.5
Febrifuge (15)41.2
Hypoglycemic (2, 12)72.1
Carminative (9, 15)61.8
Hemostatic (9)51.5
Asthma (2, 15)51.5
Pharyngitis, laryngitis (2, 9)61.8

Satureja cuneifolia Ten.Wild savoryEshabat-el- wasab
Za’atar farisi
Fp
St
I: infusionGastrointestinal disorders, (carminative, stomachic) (8, 25)72.1
Spasmolytic (25)51.5
Headache (26)41.2

Satureja thymbra L.Thyme-leaved savoryZa’atar khlat
Za’atar bou khlayt
Za’atar rumi
Za’atar franji
Za’atar-al-hamir
Za’atar
FpI: infusion, EO, and foodAntiseptic, antimicrobial, antifungal (2, 3, 12)134.0
Cough (3, 12)41.2
Blood purifying (2)30.9
Anti-inflammatory (12, 14)41.2
Nephropathy (3)30.9
LeI: infusion 50 g/L, 1 cup 3 times a dayAntidiarrheal (8, 9)61.8
Cough (9)41.2
Cardiotonic (8)41.2
Paralysis (8)30.9

Thymbra spicata L.Wild thymeZa’atar khlat
Za’atar bou khlayt
Za’atar
FpI: infusion, EO, and foodAntimicrobial, antifungal (2, 3, 20, 26)144.3
Cough (3, 20, 26)92.8
Arteriosclerosis, cardiotonic (2, 20)82.5
Blood purifying (20, 26)61.8
Insomnia (3)51.5
WpE: gargling or masticationToothache (20)51.5
I: decoctionEmmenagogue (20)30.9
Hypoglycemic (20, 21)41.2
Sterility (17, 21)30.9
Oxytocic (21)30.9
E: decoctionOphthalmia (20, 22)82.5

Vitex agnus-castus L.Chaste treeFelfel-al-raheb
Kaff Mariam
Fl
Ft
Se
I: infusion, 1 cup dailyVermifuge (21)51.5
Gastralgia (17)41.2
Sedative (20)41.2
Hypoglycemic (20, 21)30.9
Anaphrodisiac (17)30.9
I: decoctionEmmenagogue (20)30.9
Hypoglycemic (20)30.9
Oxytocic (17)41.2
Sterility (17, 21)41.2
E: decoctionOphthalmia (20, 22)82.5

Part used: Fp = flowering parts, Le = leaves, Fl = flowers, Wp = whole plant, St = stems, Ft = fruits, Se = seeds, and Dp = dried plant. Use: E = external use; I = internal use.
Numbers from 1 to 26 are abbreviations of the 25 districts of Lebanon and the governorate of Beirut (Beirut province is undivided): Akkar 1, Aley 2, Baabda 3, Baalbek 4, Batroun 5, Beirut 6, Bint Jbeil 7, Bcharre 8, Chouf 9, Hasbaya 10, Hermel 11, Jbeil 12, Jezzine 13, Keserwan 14, Koura 15, Marjeyoun 16, Metn 17, Miniyeh-Danniyeh 18, Nabatiye 19, Rachaya 20, Sidon (Saida) 21, Tripoli 22, Tyre (Sour) 23, West Bekaa 24, Zahle 25, and Zgharta 26.
The symbols and Fr are used to indicate the number and frequency of people mentioning the indication in a single plant from the total number of interviewees; that is, Fr = (/total number of interviewees) × 100.
Lamiaceae species cited and reported in this table are indigenous to Lebanon, except L. angustifolia that is imported and cultivated.

The plants have been identified based on the “Nouvelle flore du Liban et de la Syrie” (Mouterde) [16] and the Med-Checklist (http://ww2.bgbm.org/mcl/). We followed the new phylogenetic classification APG II [17] in order to update the families cited in Mouterde. Voucher specimens were deposited at the Herbarium of Botany of the U.S.E.K., Lebanon.

2.3. Essential Oil Extraction

The essential oils (EOs) were obtained by hydrodistillation performed for 3 h using a Clevenger-type apparatus according to the European Pharmacopoeia [18]. Yields are given in Table 4.

2.4. Essential Oils Analyses
2.4.1. GC Analyses

Analytical gas chromatography was carried out on a Thermo Electron Corporation gas chromatograph fitted with a DB-5 MS capillary column (30 m × 0.25 mm) with 0.1 µm film thickness or a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm, film thickness 0.20 µm). Helium was the carrier gas (0.7 mL/min). The column temperature was initially set to 35°C before being gradually increased to 85°C at 5°C/min, held for 20 min at 85°C, raised to 300°C at 10°C/min, and finally held for 5 min at 300°C. Diluted 1 µL samples (1/100, v/v) were injected at 250°C manually and in the splitless mode. Flame ionisation detection (FID) was performed at 310°C.

2.4.2. GC/MS Analyses

The GC/MS analyses were performed using an Agilent 6890 gas chromatograph coupled with 5975 Mass Detector. The 7683B autosampler injected 1 µL of each oil sample. A fused silica capillary column DB-5 MS (30 m × 0.25 mm internal diameter, film thickener 0.1 µm) or a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm, film thickness 0.20 µm) was used. Helium was the carrier gas (0.7 mL/min). The oven temperature program was identical to that described in Section 2.4.1. The mass spectra were recorded at 70 eV with an ion source temperature of 310°C and a transfer line heated to 320°C. The acquisition was recorded in full scan mode (50–400 amu).

2.4.3. Identifications and Quantifications

Most constituents were identified by gas chromatography by comparing their retention indices (RI) with those from the literature [19, 20] or with those of authentic compounds obtained from Sigma-Aldrich (Lebanon). The retention indices were determined relatively to a homologous series of n-alkanes (C8 to C24) analysed under the same operating conditions. Further identification was obtained by comparing their mass spectra on both columns with those provided in the NIST and Wiley 275 libraries, our homemade library constructed with pure compounds, and EOs of known composition or with mass spectra from the literature [19, 21]. The relative concentrations of the components were calculated based on the GC peak areas without correction; they are reported in Table 4.

2.5. Antimicrobial Activity
2.5.1. Microorganisms

The antimicrobial activity of the essential oils was investigated against the Gram (−) bacterial strain Escherichia coli ATCC 25922, the Gram (+) bacterial strain Staphylococcus aureus ATCC 29213, the yeast Candida albicans ATCC 10231, and a clinical isolate of the dermatophyte Trichophyton rubrum SNB-TR [22].

2.5.2. Microdilution Method

The antimicrobial activity of the EOs was measured using a broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [2326]. The essential oils and their major components were diluted in DMSO and were tested at concentrations ranging from 512 to 16 μg/mL. The microplates were incubated at 37°C for 24 h for bacteria, 48 h for yeasts, and 5 days for dermatophytes. The minimal inhibitory concentrations (MIC) refer to the lowest concentrations preventing visible microbial growth (Table 5). Oxacillin and gentamicin (16—0.03 μg/mL) were used as reference antibiotics, while itraconazole (16—0.03 μg/mL) and fluconazole (64—0.125 μg/mL) were used as positive controls for the antifungal assays. The antimicrobial standards were purchased from Molekula, Dorset, UK, and the pure terpenes from Sigma-Aldrich, Lebanon.

3. Results and Discussion

3.1. Ethnopharmacological Data

This investigation showed that Lamiaceae species and especially the eleven ones reported in this study are still frequently used in Lebanon as herbal remedies (Table 2). Origanum syriacum and Salvia fruticosa are the two most cited plants. It should be noted that the same vernacular name is sometimes used for different species. For example, the appellation “Za’atar” is used for Satureja thymbra, Thymbra spicata, Coridothymus capitatus, and Origanum syriacum.

3.2. Plant Parts Used

The plant parts used most frequently are the flowering tops and the leaves (34.6% each), followed by the stems (11.5%), flowers (7.7%), whole plant, fruits, and seeds (3.8% each) (Table 3).


Mode of administrationNb%
Internal use2371.8
External use928.2

PreparationNb%
Infusion1640.0
Decoction717.5
EO application717.5
Food615.0
Maceration and local application25.0
Gargle12.5
Mastication12.5

Plant parts usedAbbreviatedNb%
Flowering partsFp934.6
LeavesLe934.6
StemsSt311.5
FlowersFl27.7
Whole plantWp13.8
FruitsFt13.8
SeedsSe13.8

Traditional medicinal indicationNb%
Gastrointestinal disorders (gastritis, spasmolytic, stomachic…)1312.4
Antimicrobial (antiseptic, antifungal, dermatoses)1211.4
Hypoglycemic109.5
Rheumatism98.6
Respiratory disorders (bronchitis, cough…)87.6
Antihypertensive65.7
Carminative65.7
Vermifuge43.8
Cardiotonic43.8
Febrifuge32.8
Flu/influenza32.8
Constipation32.8
Hepatitis32.8
Nephropathy32.8
Blood purifying32.8
1514.3

Number of districts describing the use of each speciesNb%
Coridothymus capitatus415.4
Lavandula stoechas623.1
Lavandula angustifolia623.1
Mentha spicata519.2
Origanum syriacum1350.0
Rosmarinus officinalis1557.7
Salvia fruticosa934.6
Satureja cuneifolia311.5
Satureja thymbra623.1
Thymbra spicata726.9
Vitex agnus-castus415.4

Nb = number of times cited in Table 1; % = percentage of each citation.
Indications cited less than three times are listed under various indications.

Coridothymus capitatusLavandula angustifoliaLavandula stoechasMentha spicata subsp. condensataOriganum syriacumRosmarinus officinalisSalvia fruticosaSatureja cuneifoliaSatureja thymbraThymbra spicataVitex agnus-castus
Flowering tops EOFlowering tops EOFlowering tops EOFlowering tops EOFlowering tops EOLeaves EOLeaves EOLeaves EOFlowering tops EOLeaves EOFlowering tops EO
EOs yields (%)1.32.30.90.81.30.62.42.12.54.10.3
Compound ID

9291035α-Thujene, MS, CoGC0.50.2tt1.00.1t0.81.31.50.1
9381076α-Pinene, MS, CoGC0.30.72.20.20.55.42.60.31.20.57.1
9531076Camphene, MS, CoGC0.20.50.60.10.11.70.90.10.40.1t
9731132Sabinene, MS, CoGC0.10.1
97513121-Octene-3-ol, MS0.30.30.50.20.10.20.2
9801118β-Pinene, MS, CoGC0.10.40.30.11.91.50.10.40.14.4
9931174Myrcene, MS, CoGC0.80.40.20.30.90.91.30.71.10.91.0
10051188α-Phellandrene, MS, CoGC0.20.1t0.10.20.10.60.10.6
10131159δ-3-Carene, MS0.10.30.1tt0.1
10131188α-Terpinene, MS, CoGC1.00.2t1.60.40.11.41.01.20.1
10251280p-Cymene, MS, CoGC9.00.16.94.121.712.2
10301203Limonene, MS, CoGC1.0
10341213Eucalyptol, MS, CoGC8.69.521.557.320.5
10451269cis-β-Ocimene, MSt2.3ttt
10501253trans-β-Ocimene, MSt0.3tt0.1tt0.10.1t0.9
10571255γ-Terpinene, MS, CoGC4.00.20.1t7.60.90.213.311.111.60.2
10581556cis-Sabinene hydrate, MS0.50.11.20.40.20.10.20.20.20.1
10861265α-Terpinolene, MS0.30.40.10.10.70.1t0.10.10.1
10791401α-Fenchone, MS36.2
10981553Linalool, MS0.745.80.20.10.90.10.3
11051430α-Thujone, MS1.0
11151449β-Thujone, MS, CoGC0.9
11161584α-Fenchol, MS0.7
1117trans-p-Menth-2-en-1-ol, MS0.10.2tt
11381475Menthone, MS5.1
11451532Camphor, MS, CoGC11.218.015.04.8
11671719Borneol, MS, CoGC0.87.50.10.17.92.1t0.30.1
11761611Terpinen-4-ol, MS1.05.80.21.70.21.00.50.20.20.30.3
11821864p-Cymen-8-ol, MS0.2
11891706α-Terpineol, MS0.20.30.20.13.14.20.20.10.10.7
11931648Myrtenal, MS0.2
11961804Myrtenol, MS, CoGC0.40.1
12151772Citronellol, MSt
12171725Verbenone, MS0.311.8
12171845trans-Carveol, MSt0.1t
12271698Myrtenyl acetate, MS1.0t0.2
12331662Pulegone, MS, CoGC78.7
12351857Geraniol, MS, CoGC0.10.10.1
12391607Thymol methyl ether, MS1.0
12451975Carvacrol methyl ether, MS0.70.11.40.1t
12591665Linalyl acetate, MS4.6
12841597Bornyl acetate, MS, CoGC0.10.50.17.00.5t
12932198Thymol, MS, CoGC29.374.40.444.50.4
12992239Carvacrol, MS, CoGC41.5t0.20.469.55.364.0t
13331709α-Terpinyl acetate, MS2.21.2
13431748Piperitone, MSt0.10.1t
13532186Eugenol, MS, CoGC0.1t0.2tt0.1t
13771497α-Copaene, MS,1.1t
14151612β-Caryophyllene, MS, CoGC1.80.60.22.81.16.38.31.20.56.6
14371628Aromadendrene, MS1.30.10.1
14521668α-Humulene, MS0.20.10.12.61.50.2
14551689β-Farnesene, MS0.10.316.1
14631661Alloaromadendrene, MS0.10.3
14641685γ-Gurjunene, MSt0.20.1t1.2
14771726Germacrene D, MS0.40.2t0.4
14871679α-Amorphene, MS0.20.2
14911756Bicyclogermacrene, MS0.40.611.8
15081741β-Bisabolene, MS0.20.20.22.1
15261773δ-Cadinene, MS0.11.8t0.10.30.1tt0.3
15532076α-Copaene-8-ol, MS4.7
15652057Ledol, MS,1.9
15772008Caryophyllene oxide, MS, CoGC0.80.31.40.60.30.70.82.00.8
15912104Viridiflorol, MS,3.61.10.3
162520881-epi-Cubenol, MS1.8
16402188τ-Cadinol, MS0.20.2
16422209τ-Muurolol, MS1.8tt
16452145Torreyol, MS1.2
16492256α-Cadinol, MS0.3
16772256Cadalene, MS0.6
16882229α-Bisabolol, MS, CoGC0.1t0.10.2
16892276Vulgarol B, MS4.7
1948Cembrene A, MS2.8
19502603Phytol, MS0.10.10.1
19742408Sclarene, MS5.1
19872447(E)-Geranyl linalool, MS3.1

Monoterpene hydrocarbons17.05.93.73.119.612.36.921.139.228.614.6
Oxygenated monoterpenes75.883.967.685.975.668.474.671.551.765.223.1
Sesquiterpene hydrocarbons2.314.43.81.59.111.73.31.30.536.4
Oxygenated sesquiterpenes0.80.615.10.60.50.71.90.12.00.87.4
Diterpene hydrocarbons7.9
Oxygenated diterpenes0.10.10.13.1

Total identified95.991.490.893.597.290.695.196.194.295.192.5

Notes: Bold numbers indicate the percentages higher than 2% to show main components; t = trace, less than 0.05%.
index on a HP-5MS column. index on an Innowax column; retention index identical to bibliography; MS: identification based on comparison of mass spectra. Co-GC: retention time identical to authentic compounds.

EOs and constituentsMicroorganisms
S. aureusE. coliC. albicansT. rubrum
ATCC 29213ATCC 25922ATCC 10231SNB-TR1

Coridothymus capitatus6412812864
Lavandula angustifolia512>512512512
Lavandula stoechas128>512512256
Mentha spicata>512>512>512512
Origanum syriacum12825612864
Rosmarinus officinalis512>512512256
Salvia fruticosa>512>512512256
Satureja thymbra128256128128
Satureja cuneifolia128256128128
Thymbra spicata12825612864
Vitex agnus castus512>512512512
Thymol128n.t.n.t.32
Carvacrol128n.t.n.t.32
Thymol : carvacrol (1 : 1)128n.t.n.t.32
Camphor>512n.t.n.t.256
Eucalyptol>512n.t.n.t.256
Linalool>512n.t.n.t.256
γ-Terpinene>512n.t.n.t.512
p-Cymene>512n.t.n.t.64
α-Fenchone>512n.t.n.t.512
Oxacillin0.5n.t.n.t.n.t.
Gentamicinn.t.8n.t.n.t.
Itraconazolen.t.n.t.4<0.03
Fluconazolen.t.n.t.162

Notes: n.t. = not tested.
3.3. Preparation and Administration

Most of the traditional remedies are administered per os or internally (71.8%) although the majority of the EOs are applied externally (57.1%). The main modes of preparation are infusion (40.0%), decoction (17.5%), EO application (17.5%), and food consumption (15.0%) (Table 3). The contribution of the volatile organic compounds (VOCs) in all of these preparations is expected to be very important owing to the large amount of VOCs in Lamiaceae. The only exception is for decoctions because this process should eliminate most of the VOCs along with steam.

3.4. Traditional Medicinal Indications

Among the multiple medical usages of these plants, the eleven Lamiaceae species are mainly used to treat gastrointestinal disorders and microbial infections (Table 3). Almost all of them are described to possess antiseptic, antimicrobial, or antifungal properties, and a significant proportion of the EOs has been reported to be applied locally to cure microbial infections (57.1%).

3.5. Number of Districts Describing the Use of Each Lamiaceae Species

The ethnopharmacological use of Rosmarinus officinalis and Origanum syriacum was mentioned by the largest number of districts (57.7 and 50%, resp.), while the medicinal use of Coridothymus capitatus, Vitex agnus-castus, and Salvia fruticosa was localized in certain regions of Lebanon (Table 3).

3.6. Comparison with the Ethnopharmacological Uses in Other Mediterranean Countries

Despite the ancestral use of medicinal plants including essential oils in Lebanon, literature reports on Lebanese ethnomedicinal practices are scarce. Nevertheless, previous works have reported the medicinal uses of Lamiaceae species in the Mediterranean basin. Indeed, some of the plant species pointed out in our study are widely distributed and widely acknowledged by local people for medicinal purposes. In many cases, the uses reported in other countries are somewhat comparable to those found in Lebanon. For example, the cultivated lavender Lavandula angustifolia is used in Italy and Turkey as a sedative and antiseptic and to treat cold and rheumatism [2729]. As for the wild lavender, Lavandula stoechas, it is used in Turkey and Spain for gastrointestinal and cardiovascular diseases [3034]. Other examples include Coridothymus capitatus and Salvia fruticosa used in Palestine and Israel to treat cold and gastrointestinal disorders [3537], thymbra spicata used in Turkey for its cardiotonic and hypoglycemic properties, or to treat cough and arthrosclerosis [29, 30, 32], Vitex agnus-castus used in Palestine to treat eye inflammation [38], and Mentha spicata and Rosmarinus officinalis that are both used in Italy in the same way as in Lebanon as antiseptics and antimicrobials [27, 39].

On the other hand, little is known on the plant species with restricted distribution areas, like Origanum syriacum that is mainly used to treat cold symptoms in Turkey [40] and stomach pain in Jordan [41]. It is also the case of Satureja cuneifolia and Satureja thymbra that are used in Turkey as immunotonic and cardiotonic and to treat cold and flu symptoms [32, 42].

3.7. Essential Oils Analyses

Since the VOCs seemed to be relevant in the context of the traditional medicinal use of Lebanese Lamiaceae, it was pertinent to study the chemical composition of their EOs. These are reported in Table 4; the extraction yields and the relative proportions of the components are given.

The yields (v/w, relative to dry weight material) obtained by hydrodistillation ranged from 0.3% from V. agnus-castus flowering tops to 4.1% from T. spicata leaves. GC and GC-MS analyses led to the identification of 75 components accounting for 90.6 to 97.2% of the total oils (Table 4). It was found that the EOs were essentially composed of oxygenated monoterpenes (51.7% to 85.9%), the only exception being that from Vitex agnus-castus which was mainly composed of sesquiterpene hydrocarbons (36.4%). Thymol and carvacrol were present in a high relative proportion in several EOs of these Lebanese chemotypes. Thymol was the major constituent of Origanum syriacum (74.4%), Satureja thymbra (44.5%), and Coridothymus capitatus (29.3%) EOs, while carvacrol was highly abundant in the EOs of Satureja cuneifolia (69.5%), Thymbra spicata (64.0%), and Coridothymus capitatus (29.3%). All of these species were also rich in p-cymene andγ-terpinene. The oils of Salvia fruticosa, Rosmarinus officinalis, and Vitex agnus-castus were essentially composed of eucalyptol representing 57.3%, 21.5%, and 20.5% of the total oils, respectively. Pulegone was the main component of the EO of Mentha spicata accounting for 78.7% of the oil. Wild and cultivated lavender EOs were significantly different; Lavandula stoechas (wild lavender) was mainly composed of α-fenchone (26.2%) while linalool (45.8%) was the major constituent of Lavandula angustifolia (cultivated lavender).

3.8. Comparison of the Main Components of the Lebanese Lamiaceae Species with Other Countries

The EOs of Vitex agnus-castus, Lavandula stoechas, and Salvia fruticosa have a very similar chemical composition compared to other countries [4348]. Lavandula angustifolia and Coridothymus capitatus Lebanese EOs are different than those from other regions. According to our study, Lavandula angustifolia EO contains a lower relative proportion of linalyl acetate [49] and Coridothymus capitatus is richer in thymol [50, 51]. The chemical composition of the EO of Rosmarinus officinalis is similar to that reported in Greece [52] but is different from the ones reported in Turkey and Tunisia where the main component of the Lebanese EO, eucalyptol, is absent [53, 54]. Both thymol and carvacrol chemotypes have been previously reported for our thymol-rich EOs like Satureja thymbra [55, 56] and Origanum syriacum [57] or those in which carvacrol is the main constituent such as Thymbra spicata [55, 58] and Satureja cuneifolia [59, 60]. Likewise, Mentha spicata oil reported in our study belongs to the pulegone chemotype, while a carvone chemotype has also been described in other regions [61, 62].

3.9. Antimicrobial Activity

The minimum inhibitory concentrations (MICs) of the Lamiaceae essential oils are presented in Table 5. An oil was considered active if the minimal inhibitory concentration was 128 µg/mL or below [63]. The clinical isolate T. rubrum SNB-TR1 was the most sensitive, followed by the Gram (−) bacterium S. aureus and the yeast C. albicans, whereas the Gram (+) bacterium E. coli was more resistant. The oil of Coridothymus capitatus was the only EO to possess a significant antibacterial activity against E. coli with a MIC value of 128 µg/mL. This EO is rich in both thymol and carvacrol (29.3 and 41.5%, resp.). Overall, plants EOs with high relative amounts of thymol and/or carvacrol were the most active against S. aureus, T. rubrum, and C. albicans with MIC values in the range of 64–128 µg/mL.

To confirm the origin of the observed antimicrobial activity, the major constituents were tested against the two microorganisms that showed the greatest sensitivity, S. aureus and T. rubrum. Indeed, among the tested terpenes, only thymol and carvacrol showed significant antibacterial activity against S. aureus (MIC 128 µg/mL). Against T. rubrum, these two compounds were also very active (MIC 32 µg/mL), followed by p-cymene (MIC 64 µg/mL). The antimicrobial potential of a combination of thymol and carvacrol in equal proportions was also measured but no synergistic effect was detected. The MIC of the combination of these two compounds was identical to that of each separate compound. The other important constituents, that is, camphor, eucalyptol, linalool, γ-terpinene, and α-fenchone, did not show any significant antimicrobial activity (Table 5).

It has been previously reported that essential oils of Origanum and Thymus species contain mainly phenolic monoterpenes such as carvacrol and thymol and their activities are often attributed to these compounds [6468].

Our data confirm that these plants or their EOs could indeed be used in local applications for treating mycoses and demonstrate that combinations of thymol and carvacrol are not needed to account for the antifungal property of an EO.

3.10. Correlation Ethnopharmacology: Antimicrobial Activity

Ten species out of the eleven most cited Lamiaceae are used in the Lebanese traditional medicine as antiseptic or antimicrobial agents. Some are even cited specifically as antifungals (3 out of 11). Our results corroborate the antimicrobial indications for Coridothymus capitatus, Origanum syriacum, Lavandula stoechas, Satureja thymbra, and Thymbra spicata, indicating that the use of these plant species is most likely linked to the antimicrobial potential of their VOCs. For example, the flowering parts of C. capitatus are used as antiseptic and to treat dermatosis, and our results showed that the EO of the flowering tops can be considered active on all strains tested. The flowering parts of O. syriacum, S. thymbra, and T. spicata are also used in Lebanon as antiseptic and antimicrobial agents and their EOs proved to be notably active against S. aureus, C. albicans, and T. rubrum (Table 5).

4. Conclusion

In conclusion, the ethnobotanical and ethnopharmacological survey of the Lamiaceae plants confirmed that their medical values are widely acknowledged among herbalists and rural communities and that this family of plants is still frequently used in the traditional medicine of Lebanon to treat many ailments, including microbial infections.

This study highlights the in vitro antimicrobial activity of some Lebanese Lamiaceae EOs against human pathogens. The antimicrobial potential of these EOs originates from their high content in either thymol or carvacrol. These results validate the traditional antimicrobial use of Lamiaceae and lead us to believe that the use of the most active ones of these plants (or their EOs) can be promoted for the treatment of mycoses under topic applications. It should be noted that Lamiaceae herbs have high consumption in the traditional medicine in Lebanon. This might indicate innocuousness [69] although toxicological studies on these species should be encouraged.

Competing Interests

The authors declare that they have no competing interests.

Acknowledgments

This work has benefited from an “Investissement d’Avenir” Grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01).

References

  1. World Health Organization (WHO), “Antimicrobial resistance,” 2014, http://www.who.int/mediacentre/factsheets/fs194/en. View at: Google Scholar
  2. C. T. Kåhrström, “Entering a post-antibiotic era?” Nature Reviews Microbiology, vol. 11, no. 3, p. 146, 2013. View at: Publisher Site | Google Scholar
  3. A. J. Alanis, “Resistance to antibiotics: are we in the post-antibiotic era?” Archives of Medical Research, vol. 36, no. 6, pp. 697–705, 2005. View at: Publisher Site | Google Scholar
  4. A. M. Viens and J. Littmann, “Is antimicrobial resistance a slowly emerging disaster?” Public Health Ethics, vol. 8, no. 3, pp. 255–265, 2015. View at: Publisher Site | Google Scholar
  5. F. Bakkali, S. Averbeck, D. Averbeck, and M. Idaomar, “Biological effects of essential oils—a review,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 446–475, 2008. View at: Publisher Site | Google Scholar
  6. A. E. Edris, “Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review,” Phytotherapy Research, vol. 21, no. 4, pp. 308–323, 2007. View at: Publisher Site | Google Scholar
  7. A. R. Bilia, C. Guccione, B. Isacchi, C. Righeschi, F. Firenzuoli, and M. C. Bergonzi, “Essential oils loaded in nanosystems: a developing strategy for a successful therapeutic approach,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 651593, 14 pages, 2014. View at: Publisher Site | Google Scholar
  8. D. S. Alviano and C. S. Alviano, “Plant extracts: search for new alternatives to treat microbial diseases,” Current Pharmaceutical Biotechnology, vol. 10, no. 1, pp. 106–121, 2009. View at: Publisher Site | Google Scholar
  9. R. M. Harley, S. Atkins, A. L. Budantsev et al., “Labiatae,” in Flowering Plants · Dicotyledons: Lamiales (except Acanthaceae including Avicenniaceae), J. W. Kadereit, Ed., pp. 167–275, Springer, Berlin, Germany, 2004. View at: Google Scholar
  10. D. Rivera Nunez and C. Obon de Castro, “The ethnobotany of the old world labiatae,” in Advances in Labiatae Science, R. M. Harley and T. Reynolds, Eds., pp. 455–474, Royal Botanic Gardens, Kew, Richmond, UK, 1992. View at: Google Scholar
  11. M. El Beyrouthy, W. Dhifi, and N. Arnold, “Ethnopharmacological survey of the indigenous Lamiaceae from Lebanon,” Acta Horticulturae (ISHS), vol. 997, no. 33, pp. 257–275, 2013. View at: Google Scholar
  12. C. Giuliani and L. Maleci Bini, “Insight into the structure and chemistry of glandular trichomes of Labiatae, with emphasis on subfamily Lamioideae,” Plant Systematics and Evolution, vol. 276, no. 3-4, pp. 199–208, 2008. View at: Publisher Site | Google Scholar
  13. M. El Beyrouthy, N. Arnold, A. Delelis-Dusollier, and F. Dupont, “Plants used as remedies antirheumatic and antineuralgic in the traditional medicine of Lebanon,” Journal of Ethnopharmacology, vol. 120, no. 3, pp. 315–334, 2008. View at: Publisher Site | Google Scholar
  14. M. E. Beyrouthy, “Contribution à l'ethnopharmacologie libanaise et aux Lamiaceae du Liban,” Acta Botanica Gallica, vol. 156, no. 3, pp. 515–521, 2009. View at: Publisher Site | Google Scholar
  15. G. Penso, “The role of WHO in the selection and characterization of medicinal plants (vegetable drugs),” Journal of Ethnopharmacology, vol. 2, no. 2, pp. 183–188, 1980. View at: Publisher Site | Google Scholar
  16. P. Mouterde, Nouvelle Flore du Liban et de la Syrie, Distribution Librairie Orientale, Beirut, Lebanon, 1983.
  17. B. Bremer, K. Bremer, M. W. Chase et al., “An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG II,” Botanical Journal of the Linnean Society, vol. 141, no. 4, pp. 399–436, 2003. View at: Publisher Site | Google Scholar
  18. European Pharmacopoeia, Council of Europe, Strasbourg, France, 3rd edition, 1997.
  19. W. Jennings and T. Shibamoto, Qualitative Analysis of Flavour and Fragrance Volatiles by Glass Capillary Gas Chromatography, Academic Press, New York, NY, USA, 1980.
  20. N. W. Davies, “Gas chromatographic retention indices of monoterpenes and sesquiterpenes on methyl silicon and Carbowax 20M phases,” Journal of Chromatography A, vol. 503, no. 1, pp. 1–24, 1990. View at: Publisher Site | Google Scholar
  21. R. P. Adams, Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy, Allured, Carol Stream, Ill, USA, 2007.
  22. M. Khoury, M. El Beyrouthy, N. Ouaini, M. Iriti, V. Eparvier, and D. Stien, “Chemical Composition and Antimicrobial Activity of the Essential Oil of Juniperus excelsa M. Bieb. Growing Wild in Lebanon,” Chemistry and Biodiversity, vol. 11, no. 5, pp. 825–830, 2014. View at: Google Scholar
  23. Clinical and Laboratory Standards, “Reference method for broth dilution antifungal susceptibility testing of filamentous fungi,” Approved Standard M38-A2, 2nd edition, CLSI, Wayne, Pa, USA, 2008. View at: Google Scholar
  24. Clinical and Laboratory Standards, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard M27-A3, CLSI, Wayne, Pa, USA, 3rd edition, 2008.
  25. Clinical and Laboratory Standards, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard M7-A8, CLSI, Wayne, Pa, USA, 8th edition, 2009.
  26. A. M. S. Rodrigues, P. N. E. T. Theodoro, V. Eparvier et al., “Search for antifungal compounds from the wood of durable tropical trees,” Journal of Natural Products, vol. 73, no. 10, pp. 1706–1707, 2010. View at: Publisher Site | Google Scholar
  27. B. Menale, O. De Castro, C. Cascone, and R. Muoio, “Ethnobotanical investigation on medicinal plants in the Vesuvio National Park (Campania, Southern Italy),” Journal of Ethnopharmacology, vol. 192, pp. 320–349, 2016. View at: Publisher Site | Google Scholar
  28. C. Leto, T. Tuttolomondo, S. La Bella, and M. Licata, “Ethnobotanical study in the Madonie Regional Park (Central Sicily, Italy)—medicinal use of wild shrub and herbaceous plant species,” Journal of Ethnopharmacology, vol. 146, no. 1, pp. 90–112, 2013. View at: Publisher Site | Google Scholar
  29. I. Ugulu, S. Baslar, N. Yorek, and Y. Dogan, “The investigation and quantitative ethnobotanical evaluation of medicinal plants used around Izmir province, Turkey,” Journal of Medicinal Plants Research, vol. 3, no. 5, pp. 345–367, 2009. View at: Google Scholar
  30. R. Polat and F. Satil, “An ethnobotanical survey of medicinal plants in Edremit Gulf (Balikesir—Turkey),” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 626–641, 2012. View at: Publisher Site | Google Scholar
  31. M. Sağıroğlu, S. Dalgıç, and S. Toksoy, “Medicinal plants used in Dalaman (Muğla), Turkey,” Journal of Medicinal Plants Research, vol. 7, no. 28, pp. 2053–2066, 2013. View at: Publisher Site | Google Scholar
  32. S. A. Sargin, S. Selvi, and V. López, “Ethnomedicinal plants of Sarigöl district (Manisa), Turkey,” Journal of Ethnopharmacology, vol. 171, pp. 64–84, 2015. View at: Publisher Site | Google Scholar
  33. B. Gürdal and Ş. Kültür, “An ethnobotanical study of medicinal plants in Marmaris (Muğla, Turkey),” Journal of Ethnopharmacology, vol. 146, no. 1, pp. 113–126, 2013. View at: Publisher Site | Google Scholar
  34. F. M. Vázquez, M. A. Suarez, and A. Pérez, “Medicinal plants used in the Barros Area, Badajoz Province (Spain),” Journal of Ethnopharmacology, vol. 55, no. 2, pp. 81–85, 1997. View at: Publisher Site | Google Scholar
  35. N. S. A. Hinnawi, An ethnobotanical study of wild edible plants in the Northern West Bank “Palestine” [Thesis], An-Najah National University, Nablus, Palestine, 2010.
  36. M. S. Ali-Shtayeh, Z. Yaniv, and J. Mahajna, “Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 221–232, 2000. View at: Publisher Site | Google Scholar
  37. E. Lev, “Ethno-diversity within current ethno-pharmacology as part of Israeli traditional medicine—a review,” Journal of Ethnobiology and Ethnomedicine, vol. 2, article 4, 2006. View at: Publisher Site | Google Scholar
  38. N. Jaradat and J. Al-Aqsa, “Medical plants utilized in Palestinian folk medicine for treatment of diabetes mellitus and cardiac diseases,” Journal of Al-Aqsa University, no. 9, pp. 1–22, 2005. View at: Google Scholar
  39. P. Fortini, P. Di Marzio, P. Guarrera, and M. Iorizzi, “Ethnobotanical study on the medicinal plants in the Mainarde Mountains (central-southern Apennine, Italy),” Journal of Ethnopharmacology, vol. 184, pp. 208–218, 2016. View at: Publisher Site | Google Scholar
  40. S. Demirci and N. Özhatay, “An ethnobotanical study in Kahramanmaraş (Turkey); wild plants used for medicinal purpose in Andırın, Kahramanmaraş,” Turkish Journal of Pharmaceutical Sciences, vol. 9, no. 1, pp. 75–92, 2012. View at: Google Scholar
  41. S. A. S. Oran and D. M. H. Al-Eisawi, “Ethnobotanical survey of the medicinal plants in the central mountains (North-South) in Jordan,” Journal of Biodiversity and Environmental Sciences, vol. 6, no. 3, pp. 381–400, 2015. View at: Google Scholar
  42. S. A. Sargin, E. Akçicek, and S. Selvi, “An ethnobotanical study of medicinal plants used by the local people of Alaşehir (Manisa) in Turkey,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 860–874, 2013. View at: Publisher Site | Google Scholar
  43. D. Stojković, M. Soković, J. Glamočlija et al., “Chemical composition and antimicrobial activity of Vitex agnus-castus L. fruits and leaves essential oils,” Food Chemistry, vol. 128, no. 4, pp. 1017–1022, 2011. View at: Publisher Site | Google Scholar
  44. A. Habbab, K. Sekkoum, N. Belboukhari, A. Cheriti, and H. Y. Aboul-Enein, “Essential oil chemical composition of Vitex agnus-castus L. from Southern-West Algeria and its antimicrobial activity,” Current Bioactive Compounds, vol. 12, no. 1, pp. 51–60, 2016. View at: Publisher Site | Google Scholar
  45. C. N. Hassiotis, “Chemical compounds and essential oil release through decomposition process from Lavandula stoechas in Mediterranean region,” Biochemical Systematics and Ecology, vol. 38, no. 4, pp. 493–501, 2010. View at: Publisher Site | Google Scholar
  46. H. Kirmizibekmez, B. Demirci, E. Yeşilada, K. H. C. Başer, and F. Demirci, “Chemical composition and antimicrobial activity of the essential oils of Lavandula stoechas L. ssp. stoechas growing wild in Turkey,” Natural Product Communications, vol. 4, no. 7, pp. 1001–1006, 2009. View at: Google Scholar
  47. I. Cvetkovikj, G. Stefkov, M. Karapandzova, and S. Kulevanova, “Essential oil composition of Salvia fruticosa Mill. populations from Balkan Peninsula,” Macedonian Pharmaceutical Bulletin, vol. 61, no. 1, pp. 19–26, 2015. View at: Google Scholar
  48. J. Z. Al-Kalaldeh, R. Abu-Dahab, and F. U. Afifi, “Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells,” Nutrition Research, vol. 30, no. 4, pp. 271–278, 2010. View at: Publisher Site | Google Scholar
  49. R. Prusinowska and K. B. Śmigielski, “Composition, biological properties and therapeutic effects of lavender (Lavandula angustifolia L). A review,” Herba Polonica, vol. 60, no. 2, pp. 56–66, 2014. View at: Publisher Site | Google Scholar
  50. F. Tateo, M. Mariotti, and M. Bononi, “Essential oil composition and enantiomeric distribution of some monoterpenoid components of Coridothymus capitatus (L.) Rchb. Grown on the Island of Kos (Greece),” Journal of Essential Oil Research, vol. 10, no. 3, pp. 241–244, 1998. View at: Publisher Site | Google Scholar
  51. G. Economou, G. Panagopoulos, P. Tarantilis et al., “Variability in essential oil content and composition of Origanum hirtum L., Origanum onites L., Coridothymus capitatus (L.) and Satureja thymbra L. populations from the Greek island Ikaria,” Industrial Crops and Products, vol. 33, no. 1, pp. 236–241, 2011. View at: Publisher Site | Google Scholar
  52. G. Beretta, R. Artali, R. M. Facino, and F. Gelmini, “An analytical and theoretical approach for the profiling of the antioxidant activity of essential oils: the case of Rosmarinus officinalis L.,” Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 5, pp. 1255–1264, 2011. View at: Publisher Site | Google Scholar
  53. S. Irmak, K. Solakyildirim, A. Hesenov, and O. Erbatur, “Study on the stability of supercritical fluid extracted rosemary (Rosmarinus offcinalis L.) essential oil,” Journal of Analytical Chemistry, vol. 65, no. 9, pp. 899–906, 2010. View at: Publisher Site | Google Scholar
  54. Y. Zaouali, T. Bouzaine, and M. Boussaid, “Essential oils composition in two Rosmarinus officinalis L. varieties and incidence for antimicrobial and antioxidant activities,” Food and Chemical Toxicology, vol. 48, no. 11, pp. 3144–3152, 2010. View at: Publisher Site | Google Scholar
  55. T. Marković, P. Chatzopoulou, J. Siljegović et al., “Chemical analysis and antimicrobial activities of the essential oils of Satureja thymbra L. and Thymbra spicata L. and their main components,” Archives of Biological Sciences, vol. 63, no. 2, pp. 457–464, 2011. View at: Publisher Site | Google Scholar
  56. A. C. Gören, G. Topçu, G. Bilsel, M. Bilsel, J. M. Wilkinson, and H. M. A. Cavanagh, “Analysis of essential oil of Satureja thymbra by hydrodistillation, thermal desorber, and headspace GC/MS techniques and its antimicrobial activity,” Natural Product Research, vol. 18, no. 2, pp. 189–195, 2004. View at: Publisher Site | Google Scholar
  57. B. Lukas, C. Schmiderer, C. Franz, and J. Novak, “Composition of essential oil compounds from different Syrian populations of Origanum syriacum L. (Lamiaceae),” Journal of Agricultural and Food Chemistry, vol. 57, no. 4, pp. 1362–1365, 2009. View at: Publisher Site | Google Scholar
  58. G. Tümen, N. Ermin, T. Özek, M. Kürkçüoğlu, and K. H. C. Baser, “Composition of essential oils from two varieties of Thymbra spicata L.,” Journal of Essential Oil Research, vol. 6, no. 5, pp. 463–468, 1994. View at: Google Scholar
  59. B. Biavati, M. Özcan, and R. Piccaglia, “Composition and antimicrobial properties of essential oils Satureja cuneifolia Ten. and Tymbra sintenisii Bornm. et Aznav subsp. isaurica P.H. Davis,” Annals of Microbiology, vol. 54, no. 4, pp. 393–401, 2004. View at: Google Scholar
  60. C. Tümen, N. Kirimer, N. Ermin, and K. H. C. Başer, “The essential oil of Satureja cuneifolia,” Planta Medica, vol. 64, no. 1, pp. 81–83, 1998. View at: Publisher Site | Google Scholar
  61. I. Telci, I. Demirtas, E. Bayram, O. Arabaci, and O. Kacar, “Environmental variation on aroma components of pulegone/piperitone rich spearmint (Mentha spicata L.),” Industrial Crops and Products, vol. 32, no. 3, pp. 588–592, 2010. View at: Publisher Site | Google Scholar
  62. Y. Shahbazi, “Chemical composition and in vitro antibacterial activity of Mentha spicata essential oil against common food-borne pathogenic bacteria,” Journal of Pathogens, vol. 2015, Article ID 916305, 5 pages, 2015. View at: Publisher Site | Google Scholar
  63. P. Cos, A. J. Vlietinck, D. Vanden Berghe, and L. Maes, “Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’,” Journal of Ethnopharmacology, vol. 106, no. 3, pp. 290–302, 2006. View at: Publisher Site | Google Scholar
  64. R. J. W. Lambert, P. N. Skandamis, P. J. Coote, and G.-J. E. Nychas, “A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol,” Journal of Applied Microbiology, vol. 91, no. 3, pp. 453–462, 2001. View at: Publisher Site | Google Scholar
  65. M. C. Rota, A. Herrera, R. M. Martínez, J. A. Sotomayor, and M. J. Jordán, “Antimicrobial activity and chemical composition of Thymus vulgaris, Thymus zygis and Thymus hyemalis essential oils,” Food Control, vol. 19, no. 7, pp. 681–687, 2008. View at: Publisher Site | Google Scholar
  66. A. Giweli, A. M. Džamic, M. Sokovic, M. S. Ristic, and P. D. Marin, “Antimicrobial and antioxidant activities of essential oils of Satureja thymbra growing wild in libya,” Molecules, vol. 17, no. 5, pp. 4836–4850, 2012. View at: Publisher Site | Google Scholar
  67. A. Barakat, L. Hanna Wakim, N. A. Apostolides, G. Srour, and M. El Beyrouthy, “Variation in the essential oils of Thymbra spicata L. growing wild in Lebanon according to the date of harvest,” Journal of Essential Oil Research, vol. 25, no. 6, pp. 506–511, 2013. View at: Publisher Site | Google Scholar
  68. M. Zabka and R. Pavela, “Antifungal efficacy of some natural phenolic compounds against significant pathogenic and toxinogenic filamentous fungi,” Chemosphere, vol. 93, no. 6, pp. 1051–1056, 2013. View at: Publisher Site | Google Scholar
  69. The European Parliament and the Council of the European Union, “Directive 2004/24/EC,” Official Journal of the European Union, vol. 136, pp. 85–90, 2004. View at: Google Scholar

Copyright © 2016 Madona Khoury et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views4705
Downloads1421
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.